国家: 美国
语言: 英文
来源: NLM (National Library of Medicine)
LEVONORGESTREL (UNII: 5W7SIA7YZW) (LEVONORGESTREL - UNII:5W7SIA7YZW), ETHINYL ESTRADIOL (UNII: 423D2T571U) (ETHINYL ESTRADIOL - UNII:423D2T571U)
Teva Pharmaceuticals USA, Inc.
LEVONORGESTREL
LEVONORGESTREL 0.15 mg
PRESCRIPTION DRUG
Portia (levonorgestrel and ethinyl estradiol tablets USP) is indicated for use by females of reproductive potential to prevent pregnancy. Portia (levonorgestrel and ethinyl estradiol tablets USP) is contraindicated in females who are known to have the following conditions: - A high risk of arterial or venous thrombotic diseases. Examples include women who are known to: - Smoke, if over age 35 [see BOXED WARNING and WARNINGS (1) ]. - Have current or history of deep vein thrombosis or pulmonary embolism [see WARNINGS (1) ]. - Have cerebrovascular disease [see WARNINGS (1) ]. - Have coronary artery disease [see WARNINGS (1) ]. - Have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see WARNINGS (1) ]. - Have inherited or acquired hypercoagulopathies [see WARNINGS (1) ]. - Have uncontrolled hypertension or hypertension with vascular disease [see WARNINGS (3) ]. - Have diabetes mellitus and are over ag
Portia® (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/ 0.03 mg) 28 tablets are packaged in cartons of six blister cards (NDC 0555-9020-58), each card containing 28 tablets: 21 Active Tablets: Pink, round, film-coated, biconvex, unscored active tablets, debossed with stylized b on one side and 992 on the other side. 7 Inert Tablets: White, round, biconvex, unscored inert tablets, debossed with stylized b on one side and 208 on the other side. Store at 20º to 25°C (68° to 77º F) (See USP Controlled Room Temperature). Keep this and all medications out of the reach of children. Teva Pharmaceuticals USA, Inc. North Wales, PA 19454 Rev. G 11/2022
Abbreviated New Drug Application
PORTIA- LEVONORGESTREL AND ETHINYL ESTRADIOL TEVA PHARMACEUTICALS USA, INC. ---------- PORTIA (LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS USP) RX ONLY WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS CIGARETTE SMOKING INCREASES THE RISK OF SERIOUS CARDIOVASCULAR EVENTS FROM COMBINATION ORAL CONTRACEPTIVE (COC) USE. THIS RISK INCREASES WITH AGE, PARTICULARLY IN WOMEN OVER 35 YEARS OF AGE, AND WITH THE NUMBER OF CIGARETTES SMOKED. FOR THIS REASON, COCS, INCLUDING PORTIA, ARE CONTRAINDICATED IN WOMEN WHO ARE OVER 35 YEARS OF AGE AND SMOKE [SEE CONTRAINDICATIONS AND WARNINGS (1)]. DESCRIPTION Portia (levonorgestrel and ethinyl estradiol tablets USP) is a combination oral contraceptive (COC) consisting of 21 pink active tablets, each containing 0.15 mg of levonorgestrel, USP, a synthetic progestin and 30 mcg of ethinyl estradiol, USP, an estrogen, and 7 white inert tablets (without hormones). The structural formulas for the active components are: LEVONORGESTREL, USP C H O M.W. 312.45 Levonorgestrel, USP is chemically 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17- hydroxy-,(17α)-(-)-. ETHINYL ESTRADIOL, USP C H O M.W. 296.40 ® _®_ 21 28 2 C H O M.W. 296.40 Ethinyl Estradiol, USP is 19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol. Each pink active tablet contains the following inactive ingredients: anhydrous lactose, hypromellose, magnesium stearate, and microcrystalline cellulose. The ingredients in the film-coating include FD&C blue no. 1 aluminum lake, FD&C red no. 40 aluminum lake, hypromellose, polyethylene glycol, polysorbate 80, and titanium dioxide. Each white inert tablet contains the following inactive ingredients: anhydrous lactose, hypromellose, magnesium stearate, and microcrystalline cellulose. CLINICAL PHARMACOLOGY Combination oral contraceptives prevent pregnancy primarily by suppressing ovulation. INDICATIONS AND USAGE Portia (levonorgestrel and ethinyl estradiol tablets USP) is indicated for use by females of reproductive potential to prevent pregnancy. CONTRAINDICATIONS Portia ( 阅读完整的文件